Stock Market & Financial Investment News

UTi Worldwide price target lowered to $14 from $18 at StifelStifel cut its price target on UTI after the company issued a negative preannouncement and disclosed a "going concern" opinion by its auditors. The firm lowered its estimates for the company significantly, but thinks the company should be able to cut costs later this year. The firm keeps a Buy rating on the stock.